Objective: To estimate the prevalence of Mycoplasma genitalium in Toronto, Ont; detect mutations associated with macrolide and fluoroquinolone resistance; and describe treatment outcomes.
Design: Prospective, cross-sectional study.
Setting: A sexual health clinic in Toronto.
Participants: A consecutive sample of men and women attending the sexual health clinic between September 1, 2013, and December 20, 2013.
Interventions: Participants underwent testing for M genitalium, along with standard sexually transmitted infection screening. All samples that had positive results for M genitalium were tested for mutations associated with resistance to macrolides and fluoroquinolones. Mycoplasma genitalium treatment was based on resistance profile and verified with a test of cure.
Main Outcome Measures: Positive results for M genitalium and antibiotic resistance.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755653 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Women with persistent/recurrent vaginal discharge should be offered multiplex-7 PCR testing.
Eur J Obstet Gynecol Reprod Biol
January 2025
Feto Maternal Centre, Al Markhiya, Doha, Qatar; Weill Cornell Medicine, Qatar; University of Leicester, UK. Electronic address:
Background: Recurrent vaginal discharge is an important cause of repeated visits to the gynaecologists. Failure to correctly identify the causative organism with standard microscopy and culture techniques results in repeated unsuccessful treatment and the risk of developing antibiotic resistance. Multiplex PCR test is increasingly being used for investigating infections where multiple organisms may be involved.
View Article and Find Full Text PDFSuccessful Treatment of Mycoplasma genitalium Urethritis With High-Dose Tinidazole.
Sex Transm Dis
February 2025
From the Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, OH.
A 30-year-old male patient with symptomatic Mycoplasma genitalium urethritis failed treatment with oral azithromycin, 2-stage doxycycline-moxifloxacin, and minocycline. Molecular testing confirmed the presence of macrolide resistance mutations. Treatment with oral tinidazole 2 g daily for 7 days resulted in clinical and microbiologic cure.
View Article and Find Full Text PDFMycoplasma genitalium: An emerging superbug among men having sex with men.
Indian J Dermatol Venereol Leprol
January 2025
Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Screening for STIs: Results of a Health-Promotion Programme in a Portuguese University.
Microorganisms
December 2024
CERES, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
Sexually Transmitted Infections (STIs) are an important and growing public health concern. Implementation of screening programmes and awareness campaigns are crucial to mitigate this problem. A university in the central region of Portugal has devised a health-promotion programme, named , specifically directed towards the sexual health of the university community.
View Article and Find Full Text PDFSeparating Infectious Proctitis from Inflammatory Bowel Disease-A Common Clinical Conundrum.
Microorganisms
November 2024
Department of Gastroenterology, St George's University Hospital, London SW17 0QT, UK.
Proctitis refers to inflammation in the rectum and may result in rectal bleeding, discharge, urgency, tenesmus, and lower abdominal pain. It is a common presentation, particularly in genitourinary medicine and gastroenterology, as the two most common causes are sexually transmitted infections and inflammatory bowel disease. The incidence of infective proctitis is rising, particularly amongst high-risk groups, including men who have sex with men, those with HIV seropositive status, and those participating in high-risk sexual behaviours.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!